Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
- PMID: 23443359
- PMCID: PMC3591002
- DOI: 10.1038/tp.2012.150
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
Abstract
The earliest detectable change in Alzheimer's disease (AD) is the buildup of amyloid plaque in the brain. Early detection of AD, prior to irreversible neurological damage, is important for the efficacy of current interventions as well as for the development of new treatments. Although PiB-PET imaging and CSF amyloid are the gold standards for early AD diagnosis, there are practical limitations for population screening. AD-related pathology occurs primarily in the brain, but some of the hallmarks of the disease have also been shown to occur in other tissues, including the retina, which is more accessible for imaging. Retinal vascular changes and degeneration have previously been reported in AD using optical coherence tomography and laser Doppler techniques. This report presents results from analysis of retinal photographs from AD and healthy control participants from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing. This is the first study to investigate retinal blood vessel changes with respect to amyloid plaque burden in the brain. We demonstrate relationships between retinal vascular parameters, neocortical brain amyloid plaque burden and AD. A number of RVPs were found to be different in AD. Two of these RVPs, venular branching asymmetry factor and arteriolar length-to-diameter ratio, were also higher in healthy individuals with high plaque burden (P = 0.01 and P = 0.02 respectively, after false discovery rate adjustment). Retinal photographic analysis shows potential as an adjunct for early detection of AD or monitoring of AD-progression or response to treatments.
Figures
Similar articles
-
Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.Alzheimers Res Ther. 2017 Mar 1;9(1):13. doi: 10.1186/s13195-017-0239-9. Alzheimers Res Ther. 2017. PMID: 28253913 Free PMC article.
-
Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.Curr Alzheimer Res. 2013 Nov;10(9):931-9. doi: 10.2174/15672050113106660163. Curr Alzheimer Res. 2013. PMID: 24117119
-
Longitudinal retinal layer changes in preclinical Alzheimer's disease.Acta Ophthalmol. 2021 Aug;99(5):538-544. doi: 10.1111/aos.14640. Epub 2020 Oct 18. Acta Ophthalmol. 2021. PMID: 33073531 Free PMC article.
-
Potential Retinal Biomarkers in Alzheimer's Disease.Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834. Int J Mol Sci. 2023. PMID: 37958816 Free PMC article. Review.
-
Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25. J Neurol Neurosurg Psychiatry. 2012. PMID: 22733082 Review.
Cited by
-
Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect.J Clin Invest. 2022 Nov 1;132(21):e153430. doi: 10.1172/JCI153430. J Clin Invest. 2022. PMID: 36099045 Free PMC article.
-
Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.Sci Rep. 2016 Jul 8;6:29523. doi: 10.1038/srep29523. Sci Rep. 2016. PMID: 27389831 Free PMC article.
-
A systematic survey of advances in retinal imaging modalities for Alzheimer's disease diagnosis.Metab Brain Dis. 2022 Oct;37(7):2213-2243. doi: 10.1007/s11011-022-00927-4. Epub 2022 Mar 15. Metab Brain Dis. 2022. PMID: 35290546 Review.
-
Optical Coherence Tomography Angiography Evaluation of Retinal Microvasculature Before and After Carotid Angioplasty and Stenting.Sci Rep. 2019 Oct 14;9(1):14755. doi: 10.1038/s41598-019-51382-8. Sci Rep. 2019. PMID: 31611579 Free PMC article.
-
Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.Int J Mol Sci. 2022 Feb 24;23(5):2486. doi: 10.3390/ijms23052486. Int J Mol Sci. 2022. PMID: 35269629 Free PMC article. Review.
References
-
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944. - PubMed
-
- Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41:1094–1099. - PubMed
-
- Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768–778. - PubMed
-
- Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
